Nigel Courtenay-Luck
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Immunology and Allergy top 5%
Papers in
-
- Cell Adhesion Molecules Research 6
-
- Monoclonal and Polyclonal Antibodies Research 16
- Radiopharmaceutical Chemistry and Applications 6
- Co-authors
- Sridharan SoundararajanDaniel FernandesEleanor K. SpicerWeiwei ChenAgamemnon A. EpenetosMary A. RitterEnrique RozengurtAlex Legg
- Journals
- Cancer Research (4 papers)British Journal of Cancer (3 papers)Bioscience Reports (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesGreece
In The Last Decade
Nigel Courtenay-Luck
26 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 88
- Radiology, Nuclear Medicine and Imaging 656
- Immunology and Allergy 99
- Molecular Biology 971
- Oncology 331
- Immunology 219
Countries citing papers authored by Nigel Courtenay-Luck
This map shows the geographic impact of Nigel Courtenay-Luck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Courtenay-Luck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Courtenay-Luck more than expected).
Fields of papers citing papers by Nigel Courtenay-Luck
This network shows the impact of papers produced by Nigel Courtenay-Luck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Courtenay-Luck. The network helps show where Nigel Courtenay-Luck may publish in the future.
Co-authors
The 25 scholars most cited alongside Nigel Courtenay-Luck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2013 | 4 | |
| 3 | 2009 | 203 | |
| 4 | 2008 | 424 | |
| 5 | AS1411 inhibits the stabilization of bcl-2 mRNA by nucleolin in human breast cancer cells | 2007 | 2 |
| 6 | Combination of the aptamer AS1411 with paclitaxel or Ara-C produces synergistic inhibition of cancer cell growth | 2007 | 5 |
| 7 | 2006 | 1 | |
| 8 | 2006 | 49 | |
| 9 | 2005 | 18 | |
| 10 | HuBC1-IL12: A very potent immunocytokine which targets the oncofetal fibronectin in the extracellular matrix of tumor vasculature | 2004 | 1 |
| 11 | 2004 | 21 | |
| 12 | Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells. | 2000 | 59 |
| 13 | 1998 | 80 | |
| 14 | 1994 | 26 | |
| 15 | Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. | 1992 | 74 |
| 16 | 1992 | 1 | |
| 17 | 1989 | 88 | |
| 18 | 1986 | 45 | |
| 19 | 1985 | 106 | |
| 20 | 1982 | 9 |
About Nigel Courtenay-Luck
Nigel Courtenay-Luck is a scholar working on Immunology and Allergy, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Cancer Research and Immunology, having authored 28 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (16 papers), Cell Adhesion Molecules Research (6 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Glycosylation and Glycoproteins Research (5 papers), HER2/EGFR in Cancer Research (4 papers), Advanced biosensing and bioanalysis techniques (3 papers), Immunotherapy and Immune Responses (3 papers) and DNA and Nucleic Acid Chemistry (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (656 citations), Immunology and Allergy (99 citations), Molecular Biology (971 citations), Oncology (331 citations) and Immunology (219 citations). Nigel Courtenay-Luck has collaborated with scholars based in United Kingdom, United States and Greece. Frequent co-authors include Sridharan Soundararajan, Daniel Fernandes, Eleanor K. Spicer, Weiwei Chen, Agamemnon A. Epenetos, Mary A. Ritter, Enrique Rozengurt, Alex Legg, George Strang and G. Hooker. Their work appears in journals such as Cancer Research, British Journal of Cancer, Bioscience Reports, International Journal of Radiation Oncology*Biology*Physics and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.